Wendy Wei Qiao Qiu, MD, PhD
Professor
Boston University Chobanian & Avedisian School of Medicine
Psychiatry
General Psychiatry

MD, Beijing Medical University
PhD, Cornell University Medical College



Dr. Qiu is both a physician and a scientist. She is a Board Certified Psychiatrist who was trained at Tufts Medical Center and at the Payne Whitney Clinic, New York Presbyterian Hospital, Cornell Medical Center. She currently spends 50% of her time caring for patients with dementia and other psychiatric illnesses, including late life depression, and seeing patients in the ADC for the clinical trials. Many of her patients seek care at BU because they are frustrated with their deteriorating cognitive function and their behavior or mood symptoms are causing tremendous burdens for their caregivers. Motivated by her desire to help patients with devastating diseases in geriatric psychiatry, especially dementia which frequently lacks diagnostic tools and effective therapies, Dr. Qiu devotes the other 50% of her time to researching the fundamental causational mechanisms of these diseases, and to translate her findings to seeking biomarkers for the diagnoses and treatment of psychiatric illnesses.

Professor
Boston University Chobanian & Avedisian School of Medicine
Pharmacology, Physiology & Biophysics


Investigator
Framingham Heart Study


Member
Boston University
Evans Center for Interdisciplinary Biomedical Research


Co-director of Biomarker Core
Boston University Chobanian & Avedisian School of Medicine
Alzheimer's Disease Research Center




Boston University Alzheimer's Disease Research Center
08/15/2021 - 06/30/2026 (Key Person)
PI: Ann C. McKee, MD
NIH/National Institute on Aging
5P30AG072978-03

Identification and characterization of the CD31-ApoE-mCRP pathway for Alzheimer's disease in humans.
12/15/2022 - 11/30/2025 (Multi-PI)
PI: Wendy Wei Qiao Qiu, MD, PhD
NIH/National Institute on Aging
1RF1AG075832-01A1

Multi-center development of a novel diagnostic test for Alzheimer's disease
09/01/2018 - 05/31/2025 (Multi-PI)
PI: Wendy Wei Qiao Qiu, MD, PhD
NIH/National Institute on Aging
5R01AG059424-05

Supplement - Innate and Adaptive Immunity in the Pathogenesis of Glaucoma
09/01/2023 - 08/31/2024 (Subcontract PI)
Schepens Eye Research Institute NIH NEI
3R01EY031696-03S1

Metformin in Alzheimer's dementia Prevention (MAP)
05/01/2021 - 04/30/2024 (Subcontract PI)
Trustees Of Columbia University In The City Of New York NIH NIA
5R01AG062624-04

Metformin in Alzheimer's dementia Prevention (MAP)
09/15/2020 - 04/30/2024 (Subcontract PI)
Trustees Of Columbia University In The City Of New York NIH NIA
5R01AG062624-04

Metformin in Alzheimers dementia Prevention (MAP)
08/15/2019 - 04/30/2024 (Subcontract PI)
Trustees Of Columbia University In The City Of New York NIH NIA
5R01AG062624-04

Midcareer Investigator Award in Amylin, Cognition, and Alzheimer's Disease
09/01/2015 - 05/31/2022 (PI)
NIH/National Institute on Aging
5K24AG050842-05

Plasma Amylin Impact on Cognitive Function and Brain Morphology in the Framingham Heart Study
05/01/2015 - 01/31/2021 (Multi-PI)
PI: Wendy Wei Qiao Qiu, MD, PhD
NIH/National Institute on Aging
5R01AG049899-05

Quantitative systems pharmacology and translational study of pramlintide for Alzheimer's disease
09/30/2018 - 08/31/2020 (PI)
NIH/National Institute on Aging
1R56AG059805-01

Showing 10 of 14 results. Show All Results


Title


Yr Title Project-Sub Proj Pubs
2023 Identification and characterization of the CD31-ApoE-mCRP pathway for Alzheimer's disease in humans. 1RF1AG075832-01A1
2023 Characterizing the interaction of genetic vulnerabilities and chronic peripheral inflammation for AD risk 5U19AG068753-04-8063
2022 Characterizing the interaction of genetic vulnerabilities and chronic peripheral inflammation for AD risk 5U19AG068753-03-8040
2022 Multi-center development of a novel diagnostic test for Alzheimer's disease 5R01AG059424-05
2021 Characterizing the interaction of genetic vulnerabilities and chronic peripheral inflammation for AD risk 5U19AG068753-02-8040
2021 Multi-center development of a novel diagnostic test for Alzheimer's disease 5R01AG059424-04 2
2020 Characterizing the interaction of genetic vulnerabilities and chronic peripheral inflammation for AD risk 1U19AG068753-01-8040
2020 Multi-center development of a novel diagnostic test for Alzheimer's disease 5R01AG059424-03 2
2019 Multi-center development of a novel diagnostic test for Alzheimer's disease 5R01AG059424-02 2
2019 Midcareer Investigator Award in Amylin, Cognition, and Alzheimer's Disease 5K24AG050842-05 13
Showing 10 of 36 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Chen J, Doyle MF, Fang Y, Mez J, Crane PK, Scollard P, Satizabal CL, Alosco ML, Qiu WQ, Murabito JM, Lunetta KL. Peripheral inflammatory biomarkers are associated with cognitive function and dementia: Framingham Heart Study Offspring cohort. Aging Cell. 2023 Oct; 22(10):e13955.View Related Profiles. PMID: 37584418; PMCID: PMC10577533; DOI: 10.1111/acel.13955;
     
  2. Zhang Z, Gan Q, Han J, Tao Q, Qiu WQ, Madri JA. CD31 as a probable responding and gate-keeping protein of the blood-brain barrier and the risk of Alzheimer's disease. J Cereb Blood Flow Metab. 2023 Jul; 43(7):1027-1041.View Related Profiles. PMID: 37051650; PMCID: PMC10291450; DOI: 10.1177/0271678X231170041;
     
  3. Groechel RC, Tripodis Y, Alosco ML, Mez J, Qiu WQ, Mercier G, Goldstein L, Budson AE, Kowall NW, Killiany RJ. Annualized changes in rate of amyloid deposition and neurodegeneration are greater in participants who become amyloid positive than those who remain amyloid negative. Neurobiol Aging. 2023 Jul; 127:33-42.View Related Profiles. PMID: 37043881
     
  4. Na H, Yang JB, Zhang Z, Gan Q, Tian H, Rajab IM, Potempa LA, Tao Q, Qiu WQ. Peripheral apolipoprotein E proteins and their binding to LRP1 antagonize Alzheimer's disease pathogenesis in the brain during peripheral chronic inflammation. Neurobiol Aging. 2023 Jul; 127:54-69.View Related Profiles. PMID: 37060729; PMCID: PMC10198819; DOI: 10.1016/j.neurobiolaging.2023.02.013;
     
  5. Wang Y, Huang J, Ang TFA, Zhu Y, Tao Q, Mez J, Alosco M, Denis GV, Belkina A, Gurnani A, Ross M, Gong B, Han J, Lunetta KL, Stein TD, Au R, Farrer LA, Zhang X, Qiu WQ. Circulating Endothelial Progenitor Cells Reduce the Risk of Alzheimer's Disease. medRxiv. 2023 Jan 18.View Related Profiles. PMID: 36711847; PMCID: PMC9882408; DOI: 10.1101/2023.01.16.23284571;
     
  6. Bei J, Miranda-Morales EG, Gan Q, Qiu Y, Husseinzadeh S, Liew JY, Chang Q, Krishnan B, Gaitas A, Yuan S, Felicella M, Qiu WQ, Fang X, Gong B. Circulating Exosomes from Alzheimer's Disease Suppress Vascular Endothelial-Cadherin Expression and Induce Barrier Dysfunction in Recipient Brain Microvascular Endothelial Cell. J Alzheimers Dis. 2023; 95(3):869-885. PMID: 37661885; DOI: 10.3233/JAD-230347;
     
  7. Huang J, Tao Q, Ang TFA, Farrell J, Zhu C, Wang Y, Stein TD, Lunetta KL, Massaro J, Mez J, Au R, Farrer LA, Qiu WQ, Zhang X. The impact of increasing levels of blood C-reactive protein on the inflammatory loci SPI1 and CD33 in Alzheimer's disease. Transl Psychiatry. 2022 Dec 22; 12(1):523.View Related Profiles. PMID: 36550123; PMCID: PMC9780312; DOI: 10.1038/s41398-022-02281-6;
     
  8. Huang J, Stein TD, Wang Y, Ang TFA, Tao Q, Lunetta KL, Massaro J, Akhter-Khan SC, Mez J, Au R, Farrer LA, Zhang X, Qiu WQ. Blood levels of MCP-1 modulate the genetic risks of Alzheimer's disease mediated by HLA-DRB1 and APOE for Alzheimer's disease. Alzheimers Dement. 2023 May; 19(5):1925-1937.View Related Profiles. PMID: 36396603; PMCID: PMC10182187; DOI: 10.1002/alz.12851;
     
  9. Morrison MS, Aparicio HJ, Blennow K, Zetterberg H, Ashton NJ, Karikari TK, Tripodis Y, Martin B, Palmisano JN, Sugarman MA, Frank B, Steinberg EG, Turk KW, Budson AE, Au R, Goldstein LE, Jun GR, Kowall NW, Killiany R, Qiu WQ, Stern RA, Mez J, McKee AC, Stein TD, Alosco ML. Ante-mortem plasma phosphorylated tau (181) predicts Alzheimer's disease neuropathology and regional tau at autopsy. Brain. 2022 Oct 21; 145(10):3546-3557.View Related Profiles. PMID: 35554506; PMCID: PMC10233293; DOI: 10.1093/brain/awac175;
     
  10. Potempa LA, Qiu WQ, Stefanski A, Rajab IM. Relevance of lipoproteins, membranes, and extracellular vesicles in understanding C-reactive protein biochemical structure and biological activities. Front Cardiovasc Med. 2022; 9:979461. PMID: 36158829; PMCID: PMC9493015; DOI: 10.3389/fcvm.2022.979461;
     
Showing 10 of 67 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 67 publications over 27 distinct years, with a maximum of 6 publications in 2010 and 2022 and 2023

YearPublications
19841
19892
19901
19931
19942
19952
19962
19971
19981
20001
20051
20062
20074
20081
20093
20106
20111
20125
20134
20143
20171
20181
20192
20202
20215
20226
20236

2013 Boston Unviersity: J&J Clinical Innovation Award
2012 Boston University: Ignition Award
2003 New England Medical Center, Tufts University School of Medicine: CREFF Award
2002 New England Medical Center, Boston: Psychiatry Resident Award sponsored by Pfizer
2002 Tufts University School of Medicine: Resident Recognized for Excellence in Teaching
1999 Cornell Medical College, New York: Vincent du Vigneaud Prize for Excellent Research
Contact for Mentoring:

85 E. Newton St Fuller Building
Boston MA 02118
Google Map


Qiu's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department